Free Newsletter
Obama taps Sebelius as HHS chief
AIG may be grabbing the boldface headlines today, but another acronym occupies us today: HHS. We finally have our new nominee for Health and Human Services, and as expected, it's Kansas Gov. Kathleen Sebelius (photo).
The healthcare reformer is set for formal nomination today at a White House ceremony, and she'll hit the ground running tomorrow at a healthcare policy summit. Among her qualifications, supporters say, is her continual battle for healthcare reform and expanded healthcare coverage in her home state--in spite of the fact that most of her attempts were frustrated by the Republicans dominating Kansas politics. She also is a former insurance commissioner, so she has a technical grasp of the issues involved.
Some say that, with a Democratic Congress, Sebelius will have a chance to effect some of the changes she strove so mightily to achieve back home--but this time, for the entire nation. At least in the realm of expanding insurance coverage, she has Big Pharma on her side. We'll see how she fares with the rest of the business world.
- read the Washington Post story
- check out the profile in the New York Times
Related Articles:
Who's the new front-runner for HHS chief?
Who will take over at the FDA, HHS?
Frank Torti, future FDA chief?
Survey says: Nissen or Rost for FDA Commish
FDA scientist Torti moves to the helm
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





